127 related articles for article (PubMed ID: 30664711)
1. Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma.
Nagato T; Ueda S; Takahara M; Kishibe K; Komabayashi Y; Kumai T; Ohara K; Hirata-Nozaki Y; Harabuchi S; Hayashi R; Ohkuri T; Bernasconi M; Nadal D; Kobayashi H; Harabuchi Y
Lab Invest; 2019 May; 99(5):612-624. PubMed ID: 30664711
[TBL] [Abstract][Full Text] [Related]
2. Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15.
Ishii H; Takahara M; Nagato T; Kis LL; Nagy N; Kishibe K; Harabuchi Y; Klein E
Int J Cancer; 2012 Jan; 130(1):48-58. PubMed ID: 21618217
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD70 in nasal natural killer/T cell lymphoma cell lines and patients; its role for cell proliferation through binding to soluble CD27.
Yoshino K; Kishibe K; Nagato T; Ueda S; Komabayashi Y; Takahara M; Harabuchi Y
Br J Haematol; 2013 Feb; 160(3):331-42. PubMed ID: 23206232
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK/T-cell lymphoma.
Komabayashi Y; Kishibe K; Nagato T; Ueda S; Takahara M; Harabuchi Y
Am J Hematol; 2014 Jan; 89(1):25-33. PubMed ID: 23963825
[TBL] [Abstract][Full Text] [Related]
5. Soluble ICAM-1 secretion and its functional role as an autocrine growth factor in nasal NK/T cell lymphoma cells.
Takahara M; Nagato T; Komabayashi Y; Yoshino K; Ueda S; Kishibe K; Harabuchi Y
Exp Hematol; 2013 Aug; 41(8):711-8. PubMed ID: 23583640
[TBL] [Abstract][Full Text] [Related]
6. Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy.
Nagato T; Ohkuri T; Ohara K; Hirata Y; Kishibe K; Komabayashi Y; Ueda S; Takahara M; Kumai T; Ishibashi K; Kosaka A; Aoki N; Oikawa K; Uno Y; Akiyama N; Sado M; Takei H; Celis E; Harabuchi Y; Kobayashi H
Cancer Immunol Immunother; 2017 Jul; 66(7):877-890. PubMed ID: 28349165
[TBL] [Abstract][Full Text] [Related]
7. Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer/T-cell lymphoma.
Komabayashi Y; Kishibe K; Nagato T; Ueda S; Takahara M; Harabuchi Y
Hematol Oncol; 2017 Dec; 35(4):655-663. PubMed ID: 27709652
[TBL] [Abstract][Full Text] [Related]
8. Nasal natural killer (NK)/T-cell lymphoma: clinical, histological, virological, and genetic features.
Harabuchi Y; Takahara M; Kishibe K; Moriai S; Nagato T; Ishii H
Int J Clin Oncol; 2009 Jun; 14(3):181-90. PubMed ID: 19593607
[TBL] [Abstract][Full Text] [Related]
9. Novel treatment for early-stage nasal natural killer/T-cell lymphoma: intra-maxillary arterial infusion chemotherapy with concomitant radiotherapy.
Takahara M; Nagato T; Kishibe K; Ueda S; Komabayashi Y; Yamashina M; Takahashi K; Harabuchi Y
Hematol Oncol; 2017 Jun; 35(2):158-162. PubMed ID: 26563973
[TBL] [Abstract][Full Text] [Related]
10. Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on nasal natural killer/T-cell lymphoma.
Chen M; Jiang Y; Cai X; Lu X; Chao H
Int Immunopharmacol; 2021 Sep; 98():107829. PubMed ID: 34119916
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico.
Elenitoba-Johnson KS; Zarate-Osorno A; Meneses A; Krenacs L; Kingma DW; Raffeld M; Jaffe ES
Mod Pathol; 1998 Aug; 11(8):754-61. PubMed ID: 9720504
[TBL] [Abstract][Full Text] [Related]
12. LMP1 promotes nasal NK/T-cell lymphoma cell function by eIF4E via NF-κB pathway.
Sun L; Zhao Y; Shi H; Ma C; Wei L
Oncol Rep; 2015 Dec; 34(6):3264-71. PubMed ID: 26397141
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor effects of suberoylanilide hydroxamic acid on Epstein-Barr virus-associated T cell and natural killer cell lymphoma.
Siddiquey MN; Nakagawa H; Iwata S; Kanazawa T; Suzuki M; Imadome K; Fujiwara S; Goshima F; Murata T; Kimura H
Cancer Sci; 2014 Jun; 105(6):713-22. PubMed ID: 24712440
[TBL] [Abstract][Full Text] [Related]
14. Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.
Boulland ML; Meignin V; Leroy-Viard K; Copie-Bergman C; Brière J; Touitou R; Kanavaros P; Gaulard P
Am J Pathol; 1998 Oct; 153(4):1229-37. PubMed ID: 9777954
[TBL] [Abstract][Full Text] [Related]
15. Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells.
Ando S; Kawada JI; Watanabe T; Suzuki M; Sato Y; Torii Y; Asai M; Goshima F; Murata T; Shimizu N; Ito Y; Kimura H
Oncotarget; 2016 Nov; 7(47):76793-76805. PubMed ID: 27732937
[TBL] [Abstract][Full Text] [Related]
16. Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress.
Harabuchi Y; Takahara M; Kishibe K; Nagato T; Kumai T
Front Pediatr; 2019; 7():141. PubMed ID: 31041299
[TBL] [Abstract][Full Text] [Related]
17. CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.
Kumai T; Nagato T; Kobayashi H; Komabayashi Y; Ueda S; Kishibe K; Ohkuri T; Takahara M; Celis E; Harabuchi Y
Cancer Immunol Immunother; 2015 Jun; 64(6):697-705. PubMed ID: 25754123
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic predictors of nasal NK/T cell lymphoma detected by immunohistochemical staining].
Wang BY; Hong XN; Yin JL; Lu HF; Li XQ; Ma XJ; Guo Y
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):523-5. PubMed ID: 17147118
[TBL] [Abstract][Full Text] [Related]
19. [Extranodal nasal type NK/T-cell lymphoma: the expression of Epstein-Barr virus latent membrane protein 1 and its significance of prognosis].
Zhao S; Liu WP; Zhang WY; Li GD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):338-40. PubMed ID: 15931862
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of Epstein-Barr virus gene polymorphisms in nasal T/NK-cell lymphomas and normal nasal tissues: implications on virus strain selection in malignancy.
Chiang AK; Wong KY; Liang AC; Srivastava G
Int J Cancer; 1999 Jan; 80(3):356-64. PubMed ID: 9935174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
